This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.


Psychopharmacology of Anticonvulsants: Levetiracetam as a Synaptic Vesicle Protein Modulator

Stephen M. Stahl, MD, PhD

Published: September 1, 2004

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Anticonvulsants reduce seizures by a variety of unique pharmacologic mechanisms of action.1-7 Not only are the distinct pharmacologic mechanisms of action for each individual anticonvulsant being clarified but so are the therapeutic profiles for these agents. Thus, some anticonvulsants are also linked to therapeutic actions in anxiety disorders, 2,3,7

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 65

Quick Links: